Follow The Filings

NTHI NeOnc Technologies

NeOnc Technologies earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by NTHI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NTHI insider trades
  • $1.3M bought by 5 insiders
  • None no sales outside a trading plan
  • $17K sold by 1 insider under 10b5-1 plans
  1. Keithly Garnett CFO
    Planned sale
    $17K 5,000 shares at $3.36 2.1% of stake
    Traded Sep 15 Filed Sep 18
    ↗
  2. Amir F Heshmatpour CEO
    Buy
    $175K 50,000 shares at $3.50 +1.6% to stake
    Traded Sep 14–15 Filed Sep 15
    ↗
  3. Thomas C Chen CEO
    Buy
    $40K 10,798 shares at $3.70 +79% to stake
    Traded Sep 11–14 Filed Sep 15
    ↗
  4. Keithly Garnett CFO
    Buy
    $1,001 257 shares at $3.89 +0.1% to stake
    Traded Sep 14 Filed Sep 15
    ↗
  5. Amir F Heshmatpour CEO
    Buy
    $136K 37,000 shares at $3.67 +1.2% to stake
    Traded Sep 11 Filed Sep 14
    ↗
  6. Thomas C Chen CEO
    Buy
    $70K 12,757 shares at $5.49 +1346% to stake
    Traded Aug 18 Filed Aug 20
    ↗
  7. Thomas C Chen Chief Scientific Officer
    Buy
    $193K 47,207 shares at $4.09
    Traded Apr 10–Aug 17 Filed Aug 20
    ↗
  8. Amir F Heshmatpour CEO
    Buy
    $50K 9,000 shares at $5.54 +0.3% to stake
    Traded Aug 18 Filed Aug 18
    ↗
  9. Amir F Heshmatpour CEO
    Buy
    $59K 15,000 shares at $3.91 +0.5% to stake
    Traded Aug 14–17 Filed Aug 17
    ↗
  10. Amir F Heshmatpour President
    Buy
    $42K 10,000 shares at $4.16 +0.3% to stake
    Traded May 1 Filed May 4
    ↗
  11. Amir F Heshmatpour President
    Buy
    $45K 10,000 shares at $4.52 +0.3% to stake
    Traded Apr 28 Filed Apr 28
    ↗
  12. Yousha Neman-Ebrahim Chief Clinical Officer
    Buy
    $2,440 500 shares at $4.88 +0.4% to stake
    Traded Apr 23 Filed Apr 24
    ↗
  13. Keithly Garnett CFO
    Buy
    $1,614 300 shares at $5.38 +0.1% to stake
    Traded Apr 15, 2025 Filed Apr 24
    ↗
  14. Amir F Heshmatpour President
    Buy
    $49K 10,000 shares at $4.90 +0.3% to stake
    Traded Apr 23 Filed Apr 23
    ↗
  15. David Suh Jr. Chief Accounting Officer
    Buy
    $1,000 200 shares at $5.00 +0.2% to stake
    Traded Apr 9 Filed Apr 13
    ↗

Also filed in the last 12 months, not counted as buying or selling: 3 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 3.03,5.03,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
8-K/A 5.02 Filing Doc
8-K 5.07 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
DEF 14A Filing Doc
424B5 Filing Doc
8-K 7.01,9.01 Filing Doc
DEFA14A Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 1.01,3.02,3.03,5.03,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
10-K/A Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.